Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05060341 · ClinicalTrials.gov registry record
Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia
A clinical trial of Radiation-induced Xerostomia, sponsored by MeiraGTx.
- Active
- Registry status
- 22
- Enrollment target
- 4
- Study locations
NCT05060341 is a study of Radiation-induced Xerostomia that is active but no longer recruiting, run by MeiraGTx. The registered enrollment target is 22 participants. The trial reports 4 study locations across 4 states.
The verdict
NCT05060341, a study of Radiation-induced Xerostomia, is active but no longer recruiting, sponsored by MeiraGTx.
- ACTIVE NOT RECRUITING
- Registry status
- 22 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study is a long-term follow-up study for patients who have been administered AAV2hAQP1 in the Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity in Subjects with Radiation Induced Parotid Gland Hypofunction and Xerostomia
Conditions Studied
Study Locations (4)
California
- Leland Stanford Junior University - Stanford
Massachusetts
- Brigham and Women's Hospital - Boston
North Carolina
- Atrium Health - Charlotte
Ontario
- Health Sciences North - Northeast Cancer Center - Greater Sudbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2020-11-12 |
| Est. Completion | 2027-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05060341
The ClinicalTrials.gov registry entry for NCT05060341 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MeiraGTx, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Radiation-induced Xerostomia appearing as the primary indexed condition, and to 0 interventions.
NCT05060341 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Massachusetts, North Carolina.
Frequently Asked Questions
What is clinical trial NCT05060341 about?
NCT05060341 is a clinical study titled "Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia". This study is a long-term follow-up study for patients who have been administered AAV2hAQP1 in the Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity in Subjects with Radiation Induced Parotid Gland Hypofunction and Xerostomia
What is the current status of trial NCT05060341?
This trial is currently active not recruiting. The enrollment target is 22 participants. The study started on 2020-11-12. Estimated completion is 2027-03.
What conditions does trial NCT05060341 study?
This clinical trial studies the following conditions: Radiation-induced Xerostomia.
Who is sponsoring clinical trial NCT05060341?
This trial is sponsored by MeiraGTx, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05060341 being conducted?
This trial has 4 study locations across California, Massachusetts, North Carolina, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Radiation-induced Xerostomia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.